Techulon Inc

Techulon Inc. is a small biotechnology company based in Blacksburg, Virginia. The company has a team of three employees and generates an annual revenue of $2.5 million. Techulon focuses on developing innovative disease treatments, specifically targeting drug-resistant infections. Techulon's core expertise lies in creating safe and effective treatments for bacterial infections that have become resistant to traditional antibiotics. Their unique approach involves targeting bacteria at the genomic level, utilizing a proven method to defeat them. This technology results in potent drugs that are less likely to develop resistance. The company's enabling technology is a versatile platform capable of delivering nucleic acids for diverse therapeutic applications. Techulon has recently secured a substantial contract from the Defense Advanced Research Projects Agency (DARPA) worth $1.9 million. This funding will be instrumental in advancing their antimicrobial platform to combat both Gram-negative and Gram-positive bacteria. To learn more about Techulon's groundbreaking work, visit their website at techulon.com.